Deflexum AB is a Swedish AB based in Bjärred, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2000, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas ensam av Larsson, Marcus Kåre Torleif
Company purpose
Bolaget skall direkt eller indirekt bedriva teknisk utveckling, affärsverksamhet och förvaltning inom området bioteknik med inriktning mot läkemedel ävensom idka därmed förenlig verksamhet.
In its most recent annual report (2025), Deflexum AB reported revenue of SEK 0. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of SEK 317.5k.
At the end of 2025, equity financed 90.1% of the balance sheet, and current assets covered short-term debt 1 times.
Frequently asked questions
What is the Org number of Deflexum AB?
Deflexum AB is registered with Bolagsverket / SCB under Org 5566001045.
Who is the chairman of Deflexum AB?
Helge Sören Brekell chairs the board of Deflexum AB, in role since 2022.
Where is Deflexum AB headquartered?
Deflexum AB's registered address is Norra Villavägen 7 B.
